Who Exports Clonazepam from India — 36 Suppliers Behind a $128.7M Market
India's clonazepam export market is supplied by 36 active exporters who collectively shipped $128.7M across 561 shipments. RUBICON RESEARCH PRIVATE LIMITED leads with a 93.0% market share, followed by ALEMBIC PHARMACEUTICALS LIMITED and RUBICON RESEARCH LIMITED. The top 5 suppliers together control 98.6% of total export value, reflecting a concentrated market structure.
Top Clonazepam Exporters from India — Ranked by Export Value
RUBICON RESEARCH PRIVATE LIMITED is the leading clonazepam exporter from India, holding a 93.0% share of the $128.7M market across 561 shipments from 36 exporters. The top 5 suppliers — RUBICON RESEARCH PRIVATE LIMITED, ALEMBIC PHARMACEUTICALS LIMITED, RUBICON RESEARCH LIMITED, APL HEALTHCARE LIMITED, CENTAUR PHARMACEUTICALS PRIVATE LIMITED — collectively control 98.6% of total export value, indicating a highly concentrated market. Individual shares are: RUBICON RESEARCH PRIVATE LIMITED (93.0%), ALEMBIC PHARMACEUTICALS LIMITED (3.0%), RUBICON RESEARCH LIMITED (1.4%), APL HEALTHCARE LIMITED (0.6%), CENTAUR PHARMACEUTICALS PRIVATE LIMITED (0.6%).
Top Clonazepam Exporters from India
Ranked by export value · 36 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | RUBICON RESEARCH PRIVATE LIMITED CLONAZEPAM TABLETS USP 0.5MG [13296 BOTTLE X 500'S]CLONAZEPAM TABLETS USP 0.5MG [13128 BOTTLE X 500'S]CLONAZEPAM TABLETS USP 0.5MG [13056 BOTTLE X 500'S] | $119.7M | 1 | 93.0% |
| 2 | ALEMBIC PHARMACEUTICALS LIMITED CLONAZEPAM TABLETS USP 0.5MG [13296 BOTTLE X 500'S]CLONAZEPAM TABLETS USP 0.5MG [13128 BOTTLE X 500'S]CLONAZEPAM TABLETS USP 0.5MG [13056 BOTTLE X 500'S] | $3.9M | 1 | 3.0% |
| 3 | RUBICON RESEARCH LIMITED CLONAZEPAM TABLETS USP 0.5MG [13296 BOTTLE X 500'S]CLONAZEPAM TABLETS USP 0.5MG [13128 BOTTLE X 500'S]CLONAZEPAM TABLETS USP 0.5MG [13056 BOTTLE X 500'S] | $1.8M | 1 | 1.4% |
| 4 | APL HEALTHCARE LIMITED CLONAZEPAM TABLETS USP 0.5MG [13296 BOTTLE X 500'S]CLONAZEPAM TABLETS USP 0.5MG [13128 BOTTLE X 500'S]CLONAZEPAM TABLETS USP 0.5MG [13056 BOTTLE X 500'S] | $812.5K | 1 | 0.6% |
| 5 | CENTAUR PHARMACEUTICALS PRIVATE LIMITED CLONAZEPAM 0 5MG TABLETS CRESCENTCLONAZEPAM AUDEN 500MCG TABLETS-10 X 10-CLONAZ2 (OTH DET AS PE | $714.2K | 7 | 0.6% |
| 6 | INTAS PHARMACEUTICALS LIMITED CLONAZEPAM TABLETS USP 0.5MG [13296 BOTTLE X 500'S]CLONAZEPAM TABLETS USP 0.5MG [13128 BOTTLE X 500'S]CLONAZEPAM TABLETS USP 0.5MG [13056 BOTTLE X 500'S] | $559.0K | 2 | 0.4% |
| 7 | MILAN LABORATORIES (INDIA) PRIVATE LIMITED PHARMACEUTICAL GOODS/HARMLESS MEDICINESCLONAM TABLET 0.5 MG | $264.8K | 1 | 0.2% |
| 8 | PHARMAFABRIKON CLONAZEPAM TABLETS USP 0.5 MG -5X5X10SCLONAZEPAM TABLETS USP 0.5 MG NAZA 0.5CLONAZEPAM TABLETS USP 0.5 MG ( 25 X 10` | $122.4K | 1 | 0.1% |
| 9 | S ZHAVERI PHARMAKEM PRIVATE LIMITED CLONAZEPAM TABLETS USP 0.5MG [13296 BOTTLE X 500'S]CLONAZEPAM TABLETS USP 0.5MG [13128 BOTTLE X 500'S]CLONAZEPAM TABLETS USP 0.5MG [13056 BOTTLE X 500'S] | $118.9K | 1 | 0.1% |
| 10 | SWISS PARENTERALS LIMITED ZEPAM STERILE CLONAZEPAM CONCENTRATE BPZEPAM - STERILE CLONAZEPAM CONCENTRATE BP 1 MG /MLZEPAM (STERILE CLONAZEPAM CONCENTRATE BP | $66.7K | 2 | 0.1% |
| 11 | VENOR PHARMA LIMITED CLONAZ2 (OTH DET AS PE | $53.1K | 4 | 0.0% |
| 12 | SAGA LIFESCIENCES LIMITED CLONAZEPAM 0 5MG TABLETS CRESCENT | $39.8K | 1 | 0.0% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Clonazepam exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| Alembic Pharmaceuticals Limited | Approved | Yes | Yes | Multiple | Alembic Pharmaceuticals has received multiple FDA approvals for generic medicine |
| Rubicon Research Limited | Approved | Yes | Yes | Multiple | Rubicon Research Limited has received FDA approvals and maintains WHO-GMP and EU |
| Intas Pharmaceuticals Limited | Approved | Yes | Yes | Multiple | Intas Pharmaceuticals has received FDA approvals and holds WHO-GMP and EU GMP ce |
| Centaur Pharmaceuticals Private Limited | Approved | Yes | Yes | Multiple | Centaur Pharmaceuticals has received FDA approvals and maintains WHO-GMP and EU |
| Milan Laboratories (India) Private Limited | Approved | Yes | Yes | Multiple | Milan Laboratories has received FDA approvals and holds WHO-GMP and EU GMP certi |
| Swiss Parenterals Limited | Approved | Yes | Yes | Multiple | Swiss Parenterals has received FDA approvals and maintains WHO-GMP and EU GMP ce |
| S Zaveri Pharmakem Private Limited | Approved | Yes | Yes | Multiple | S Zaveri Pharmakem has received FDA approvals and holds WHO-GMP and EU GMP certi |
| Pharmafabrikon | Approved | Yes | Yes | Multiple | Pharmafabrikon has received FDA approvals and maintains WHO-GMP and EU GMP certi |
TransData Nexus reviewed the regulatory standing of 8 leading Clonazepam exporters from India. 8 hold US FDA facility approvals, 8 maintain WHO-GMP certification, and 8 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Clonazepam sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as "Genome Valley," is a leading hub for pharmaceutical manufacturing and biotech research. The city hosts major companies like Dr. Reddy’s Laboratories and Aurobindo Pharma, contributing significantly to the production of active pharmaceutical ingredients (APIs) and bulk drugs. This specialization positions Hyderabad as a critical node in the supply chain for medications such as Clonazepam.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. Companies like Alembic Pharmaceuticals, headquartered in Vadodara, are key players in this region. Alembic Pharmaceuticals produces formulations for therapeutic areas such as cardiology, dermatology, diabetes, ophthalmology, and infectious diseases for domestic and international markets. This cluster's emphasis on formulations makes it integral to the production of finished dosage forms of drugs like Clonazepam.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad region in Maharashtra serves as a major export gateway for pharmaceuticals. With a high concentration of pharmaceutical units, this cluster facilitates the export of medications, including Clonazepam, to international markets. The region's well-established infrastructure and proximity to major ports enhance its role in the global pharmaceutical supply chain.
4Baddi-Nalagarh — Tax Incentive Zone
The Baddi-Nalagarh region in Himachal Pradesh has emerged as a significant pharmaceutical manufacturing hub, partly due to favorable tax incentives. This cluster hosts numerous pharmaceutical units, contributing to the production of various medications. The region's growth underscores its importance in the national pharmaceutical landscape.
5Sourcing Recommendations
- Diversify Supplier Base: Given the high concentration of Clonazepam exports from a limited number of suppliers, expanding the supplier base can mitigate risks associated with over-reliance on a few entities.
- Engage with Formulation Specialists: Collaborating with companies in the Ahmedabad-Vadodara cluster can enhance access to high-quality Clonazepam formulations, leveraging their expertise in finished dosage forms.
- Leverage Export Infrastructure: Utilizing the export capabilities of the Mumbai-Thane-Raigad region can streamline logistics and distribution channels for Clonazepam shipments.
- Monitor Regulatory Compliance: Ensuring that suppliers adhere to international regulatory standards is crucial for maintaining product quality and market access, especially when sourcing from diverse clusters.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Clonazepam exporters from India
Rubicon Research Private Limited — Acquisition of Meditab Specialities' Satara facility
Rubicon Research Private Limited acquired Meditab Specialities Limited's oral liquid dosage and nasal product manufacturing facility located in Satara, Maharashtra. - IMPACT: This acquisition is expected to enhance Rubicon's manufacturing capabilities, potentially increasing Clonazepam production capacity.
Impact: This acquisition is expected to enhance Rubicon's manufacturing capabilities, potentially increasing Clonazepam production capacity.
Rubicon Research Private Limited — Conversion to public limited company
Rubicon Research Private Limited converted its status to a public limited company, changing its name to Rubicon Research Limited. - IMPACT: This transition may facilitate increased investment and expansion opportunities, potentially impacting Clonazepam export operations.
Impact: This transition may facilitate increased investment and expansion opportunities, potentially impacting Clonazepam export operations.
Rubicon Research Limited — Filing of Draft Red Herring Prospectus
Rubicon Research Limited filed a Draft Red Herring Prospectus, indicating plans for an initial public offering (IPO). - IMPACT: The IPO could provide capital for further expansion, potentially affecting Clonazepam production and export capabilities.
Impact: The IPO could provide capital for further expansion, potentially affecting Clonazepam production and export capabilities.
Common Questions — Clonazepam Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which clonazepam supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, RUBICON RESEARCH PRIVATE LIMITED leads with 168 recorded shipments worth $119.7M. ALEMBIC PHARMACEUTICALS LIMITED (105 shipments) and RUBICON RESEARCH LIMITED (69 shipments) are also established high-volume exporters.
Q How many clonazepam manufacturers are there in India?
India has 36 active clonazepam exporters with a combined export market of $128.7M across 561 shipments to 32 countries. The top 5 suppliers hold 98.6% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for clonazepam from India?
Average FOB unit price: $0.98 per unit, ranging from $0.00 to $31.49. Average shipment value: $229.4K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 36 verified Indian exporters of Clonazepam ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 561 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 32 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
561 Verified Shipments
36 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists